Concepedia

Stephen Eckert

SE

Statistics

Publications

21

Citations

4.2K

H-Index

17

Active since

1998

Affiliations

Synageva BioPharma (United States)(Current)

Stanford University

University of California, San Francisco

Hôpital Necker-Enfants Malades

Eli Lilly (United States)

Stephen Eckert is an author at Synageva BioPharma (United States) specializing in medicine, osteoporosis, and menopause.

Top concepts

Publications per year

1998–2017

21

Publications

21

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

Steven R. Cummings, Stephen Eckert, K A Krueger et al. · JAMA · 1999 · 1.9K citations

Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

Jane A. Cauley, Larry Norton, Marc E. Lippman et al. · Breast Cancer Research and Treatment · 2001 · 680 citations

, , +12

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency

Barbara K. Burton, Manisha Balwani, François Feillet et al. · New England Journal of Medicine · 2015 · 238 citations · Full text

Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors

Hagop M. Kantarjian, Harry P. Erba, David F. Claxton et al. · Journal of Clinical Oncology · 2009 · 192 citations · Full text

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial

Bruce Ettinger, Dennis M. Black, Bruce Mitlak et al. · Obstetrical & Gynecological Survey · 2000 · 168 citations

, , +17

Rows per page

1–5 of 21